E-LIB Suche - Ergebnisse für: Motoo Nagane

1

Safety and effectiveness of bevacizumab in Japanese patient..:

Nishikawa, Ryo ; Ura, Masako ; Shimizu, Ayaka..
Japanese Journal of Clinical Oncology. 49 (2019) 11 - p. 1016-1023 , 2019

Link: https://doi.org/10.1093/..

2

Intracerebral Tumor-Associated Hemorrhage Caused by Overexp..:

Shi-Yuan Cheng ; Motoo Nagane ; H.-J. Su Huang.
Proceedings of the National Academy of Sciences of the United States of America. 94 (1997) 22 - p. 12081-12087 , 1997

Link: https://www.jstor.org/st..

3

MDB-16. CLINICAL AND MOLECULAR CHARACTERISTICS OF JAPANESE ..:

Go, Kohichi ; Katsuma, Asako ; Makino, Yasuhide...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

4

Three-year follow-up analysis of phase 1/2 study on tirabru..:

Yonezawa, Hajime ; Narita, Yoshitaka ; Nagane, Motoo...
Neuro-Oncology Advances. 6 (2024) 1 - p. , 2024

Link: https://doi.org/10.1093/..

5

Preface for Brain Tumor Pathology vol.41 issue 2: (Special ..:

Nagane, Motoo
Brain Tumor Pathology. 41 (2024) 2 - p. 41-42 , 2024

Link: https://doi.org/10.1007/..

6

GCT-15. CLINICAL AND MOLECULAR CHARACTERIZATION OF INFANTIL..:

Fukuoka, Kohei ; Takami, Hirokazu ; Satomi, Kaishi...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

7

Distinct patterns of copy number alterations may predict po..:

Takami, Hirokazu ; Satomi, Kaishi ; Fukuoka, Kohei...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

8

The role of nonlinear dimension reduction of genome‐wide DN..:

Satomi, Kaishi ; Saito, Kuniaki ; Shimoyamada, Hiroaki...
Pathology International. 73 (2023) 10 - p. 523-526 , 2023

Link: https://doi.org/10.1111/..

9

Subtyping of Group 3/4 medulloblastoma as a potential progn..:

Fukuoka, Kohei ; Kurihara, Jun ; Shofuda, Tomoko...
Acta Neuropathologica Communications. 11 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

10

Karnofsky Performance Status and quality of life in patient..:

Arakawa, Yoshiki ; Narita, Yoshitaka ; Nagane, Motoo...
Neuro-Oncology Advances. 5 (2023) 1 - p. , 2023

Link: https://doi.org/10.1093/..

11

CTNI-81. REAL-WORLD TREATMENT RESULTS OF RELAPSED PRIMARY C..:

Nagane, Motoo ; Sasaki, Nobuyoshi ; Yamagaishi, Yuki...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v96-v97 , 2023

Link: https://doi.org/10.1093/..

12

10259-NQPC-9 CONTROVERSY ON INVASIVE AIRWAY MANAGEMENT IN P..:

Ikeda, Kensuke ; Saito, Kuniaki ; Yamagishi, Yuki...
Neuro-Oncology Advances. 5 (2023) Supplement_5 - p. v24-v24 , 2023

Link: https://doi.org/10.1093/..

13

CTNI-68. PHASE I/II STUDY OF MAINTENANCE THERAPY WITH METFO..:

Narita, Yoshitaka ; Ohno, Makoto ; Kitanaka, Chifumi...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v92-v93 , 2023

Link: https://doi.org/10.1093/..

14

10221-ML-11 A CASE OF PRIMARY CENTRAL NERVOUS SYSTEM ADULT ..:

Seiya, Yosuke ; Sasaki, Nobuyoshi ; Kobayashi, Makoto...
Neuro-Oncology Advances. 5 (2023) Supplement_5 - p. v22-v22 , 2023

Link: https://doi.org/10.1093/..

15

Diagnosis and management of complications from the treatmen..:

Weller, Michael ; Le Rhun, Emilie ; Van den Bent, Martin...
Neuro-Oncology. 25 (2023) 7 - p. 1200-1224 , 2023

Link: https://doi.org/10.1093/..